Evaluation of surrogate validation approaches accepted in German health technology assessment
Introduction: Surrogate variables are crucial in drug development, substituting endpoints that are difficult or time-consuming to collect. A frequent example is progression-free survival (PFS) as a surrogate for overall survival (OS). Among Health Technology Assessment (HTA) bodies in Europe, only the [for full text, please go to the a.m. URL]
Institutions
- Boehringer Ingelheim (Germany) (DE)
Publication Details
- Journal
- German Medical Science (German Research Foundation)
- Published
- 2025-11-03
- DOI
- https://doi.org/10.3205/25gmds035
- Primary Topic
- Health Systems, Economic Evaluations, Quality of Life
- Type
- article
- Field-Weighted Citation Impact
- 0.00